Ornidazole is an oral nitroimidazole antifungal and antiprotozoal medication. It is prescribed primarily to treat infections caused by anaerobic bacteria and certain parasitic organisms. The drug works by entering microbial cells and undergoing reduction to a reactive nitro radical. This reduced form then binds to dna and disrupts its synthesis leading to microbial death. Its activity is selective for anaerobic organisms and some protozoa that inhabit low-oxygen environments. After oral administration the compound is absorbed from the gastrointestinal tract and distributed to tissues where the infection resides. Metabolism in the liver generates active metabolites that maintain antimicrobial levels for several hours. The combined effect of dna damage and impaired replication results in the therapeutic clearance of the target infection.

Ornidazole is an oral nitroimidazole antiprotozoal and antibacterial drug used primarily to treat anaerobic infections. Its pharmacological profile includes rapid absorption followed by extensive distribution to sites of infection within the gastrointestinal tract and genitourinary system. Metabolism converts Ornidazole to an active metabolite that inhibits microbial dna synthesis by forming adducts after reduction in anaerobic organisms. This reduction step generates toxic intermediates that disrupt dna helicase and cause strand breaks leading to microbial cell death. The drug exhibits concentration dependent activity with a post-antibiotic effect that continues to suppress regrowth after levels fall. Elimination occurs mainly through hepatic metabolism and renal excretion with a half-life that supports once-daily dosing in most patients. Clinically this mechanism provides effective eradication of anaerobic bacteria and certain protozoa while sparing aerobic flora that lack the activating reductase.

Nausea may occur after taking Ornidazole. Headache is another frequently reported symptom. Some people experience a metallic taste in the mouth. Abdominal discomfort or pain can develop. Dizziness may be felt, especially when standing up quickly. Loss of appetite is occasionally observed. Skin rash or mild irritation can appear. Dry mouth sometimes accompanies the medication use.

Ornidazole may cause nausea and a metallic taste sensation. Some users report abdominal discomfort and mild indigestion. Headache and dizziness are also frequently reported. Dry skin reactions such as itching or rash can occur. Fatigue and mild weakness are sometimes experienced. Changes in taste perception, including bitterness, may appear. Occasional urinary urgency or mild irritation has been noted.